PSN:NYSEParsons Corporation Analysis
Data as of 2026-05-28 - not real-time
$58.83
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Parsons Corporation (PSN) is trading above its short‑term moving average but remains below its long‑term trend line, signaling a bearish backdrop despite a recent price rally. The technical picture shows an RSI perched in the upper zone and a bullish MACD crossover, yet the stock is flirting with a key resistance level that has capped upside in recent sessions.
Fundamentally, Q1 revenue slipped modestly year‑over‑year while organic growth stayed healthy, and the company posted a record adjusted EBITDA margin, bolstered by new defense and infrastructure contracts. Analysts’ consensus remains positive, with a “Buy” recommendation and a target price that implies modest upside, but a discounted cash‑flow model points to a valuation gap that suggests the market may be overpaying at current levels.
Fundamentally, Q1 revenue slipped modestly year‑over‑year while organic growth stayed healthy, and the company posted a record adjusted EBITDA margin, bolstered by new defense and infrastructure contracts. Analysts’ consensus remains positive, with a “Buy” recommendation and a target price that implies modest upside, but a discounted cash‑flow model points to a valuation gap that suggests the market may be overpaying at current levels.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 7/10
Key Factors
- Price approaching a well‑tested resistance zone
- Momentum indicators signal overbought conditions
- Stable trading volume supporting liquidity
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Improving operating margins and record EBITDA performance
- Pipeline of defense and infrastructure contracts
- Analyst consensus and target price indicating upside potential
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Valuation gap between market price and intrinsic DCF estimate
- Dependence on government spending and regulatory environment
- Solid cash generation but limited dividend return
Key Metrics & Analysis
Financial Health
Revenue Growth-4.10%
Profit Margin3.62%
P/E Ratio28.1
ROE11.03%
ROA4.40%
Debt/Equity61.21
P/B Ratio2.4
Op. Cash Flow$486.5M
Free Cash Flow$277.4M
Industry P/E40.9
Technical Analysis
TrendBearish
RSI67.6
Support$48.23
Resistance$60.71
MA 20$51.91
MA 50$53.10
MA 200$69.04
MACDBullish
VolumeStable
Fear & Greed Index93.32
Valuation
Fair Value$21.07
Target Price$69.64
Upside/Downside18.37%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta0.90
Volatility44.64%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.